key: cord-0897489-d1qwdh7z
authors: Herrscher, Hugo; Sauer, Benoit; Truntzer, Pierre; Robert, Caroline
title: Abscopal anti-tumor effect in a patient with melanoma and COVID-19
date: 2021-03-14
journal: Eur J Cancer
DOI: 10.1016/j.ejca.2021.03.003
sha: d39e3c7e60e0391a0262ce16d7320543d16a92a5
doc_id: 897489
cord_uid: d1qwdh7z

nan

Abscopal effect has been described for the first time by Mole in 1953 (1) to define a tumor 3 response at distance from an irradiated lesion. Several cases of abscopal effect have been 4 reported in patients treated with radiotherapy while receiving immune checkpoint inhibitors 5 (ICI) (2) . However, this phenomenon unfortunately is a very rare occurrence. Infectious 6 diseases are known to trigger the innate immune system and may even induce tumor 7 responses (3). We report here the first case of abscopal effect in a patient treated with 8 radiotherapy for a metastatic melanoma during the course of an infection by the new 9 coronavirus SARS-CoV-2, in a melanoma patient. 10 11

A 84-year-old woman was diagnosed in February 2020 with a peritoneal and nodal recurrence 13 of a BRAF V600E mutated melanoma. She was otherwise treated for an atrial fibrillation, a 14 type II diabetes and a chronic kidney disease with a usual glomerular filtration rate about 40 15 mL/min. 16

In July 2020, a treatment with dabrafenib and trametinib was introduced but had to be 17 discontinued after two months of therapy, in September 2020 for cardiac toxicity. Because of 18 her poor general performans status, exclusive palliative care was then proposed. 19

In December 2020, she received a symptomatic irradiation of a painful 4 x 3 cm metastatic 20 cervical node delivering 20 Gy in 5 fractions of 4 Gy. 21

One month later, she was admitted in our hospital for a symptomatic Covid-19. On the 22 computed tomography (CT)-scan evaluation, she had radiologic signs of pulmonary Covid-19 23 but also an unexpected impressive objective tumor response with a shrinkage of 20 -25% for 24 all metastases (figure 1). tissue sarcoma after injection of streptococcal organisms (3) . Years later, the implication of 29 the immune system, modulated by infectious agents via innate immune receptors such as Toll 30 like receptors (TLR), was determined to be the mechanism of the tumor response (4). On the 31 other hand, radiation therapy is known since 1953 for having the capacity to be immunogenic 32

(1) and to induce an abscopal effect. The mechanism of abscopal effect is supposed to rely on 33 a radiotherapy-induced increase of tumor-associated antigens (TAA) presentation by myeloid 34 antigen presenting cells (APC) of the stroma (5) . Radiotherapy can also release danger-35 associated molecular patterns (DAMPs) ligands for TLR as well as cytokines that create an 36 immunogenic microenvironment further increasing the TAA presentation to CD8 + cytotoxic T 37

In the case of our patient, the deep tumor response could not be explained by a delayed effect 39 of the treatment with dabrafenib + trametinib that had been stopped 3 months before since To the best of our knowledge, this is the first case of tumor abscopal effect potentially 52 induced by the COVID-19. More cases will be needed to validate this hypothesis. 53 54

The COVID-19 may increase anti-tumoral immune response against melanoma by enhancing 56 abscopal effect in patients treated with radiotherapy. 57 58 J o u r n a l P r e -p r o o f

Whole body irradiation; radiobiology or medicine?

Immunologic correlates of the abscopal effect in a patient with melanoma

Coley's toxins in perspective

Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

Using immunotherapy to boost the abscopal effect

The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence

Immune response in COVID-19: What do we